Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-12-007249
Filing Date
2012-07-27
Accepted
2012-07-27 13:53:27
Documents
14
Period of Report
2012-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K immucor_10k-053112.htm 10-K 4447296
2 EXHIBIT 10.9 ex10-9.htm EX-10.9 140054
3 EXHIBIT 10.15 ex10-15.htm EX-10.15 179538
4 EXHIBIT 21 ex21.htm EX-21 6117
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 14418
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 14568
7 EXHIBIT 32.1 ex32-1.htm EX-32.1 5128
8 EXHIBIT 32.2 ex32-2.htm EX-32.2 5499
  Complete submission text file 0001437749-12-007249.txt   30745089

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE blud-20120531.xml EX-101.INS 7320948
10 XBRL TAXONOMY EXTENSION SCHEMA blud-20120531.xsd EX-101.SCH 95894
11 XBRL TAXONOMY EXTENSION CALCULATION blud-20120531_cal.xml EX-101.CAL 77248
12 XBRL TAXONOMY EXTENSION DEFINITION blud-20120531_def.xml EX-101.DEF 572643
13 XBRL TAXONOMY EXTENSION LABELS blud-20120531_lab.xml EX-101.LAB 634136
14 XBRL TAXONOMY EXTENSION PRESENTATION blud-20120531_pre.xml EX-101.PRE 582277
Mailing Address 3130 GATEWAY DR P O BOX 5625 NORCROSS GA 30091-5625
Business Address 3130 GATWAY PO BOX 5625 NORCROSS GA 30091 770 441 2051
IMMUCOR INC (Filer) CIK: 0000736822 (see all company filings)

EIN.: 222408354 | State of Incorp.: GA | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-14820 | Film No.: 12989933
SIC: 2835 In Vitro & In Vivo Diagnostic Substances